NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway

International Immunology

Volumn 20, Issue 10, 2008, Pages 1343-1349

  Ito, Akiko ^a   Shimura, Hideki ^a   Nitahara, Ayano ^a   Tomiyama, Katsuhiro ^a   Ito, Masaaki ^a   Kanekura, Takuro ^b   Okumura, Ko ^c   Yagita, Hideo ^c   Kawai, Kazuhiro ^b  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

^c JUNTENDO UNIVERSITY   (Japan)

Author keywords

NKG2D; Transplantation

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL KILLER CELL RECEPTOR NKG2D;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CONTROLLED STUDY; CYTOTOXICITY; EPITHELIUM CELL; FEMALE; GRAFT NECROSIS; GRAFT REJECTION; GRAFT SURVIVAL; HISTOPATHOLOGY; LYMPHOCYTE DEPLETION; LYMPHOCYTE FUNCTION; MACROPHAGE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCID MOUSE; SKIN GRAFT; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; FEMALE; GENES, MHC CLASS II; GRAFT REJECTION; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, SCID; RECEPTORS, IMMUNOLOGIC; SKIN TRANSPLANTATION; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS;

EID: 52949084363     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn092     Document Type: Article

References (34)

1. Game, D. S. and Lechler, R. I. 2002. Pathways of allorecognition: implications for transplantation tolerance. Transpl. Immunol. 10:101.
2. Le Moine, A., Goldman, M. and Abramowicz, D. 2002. Multiple pathways to allograft rejection. Transplantation 73:1373.
3. Lee, R. S., Grusby, M. J., Glimcher, L. H., Winn, H. J. and Auchincloss, H., Jr 1994. Indirect recognition by helper cells can induce donor-specific cytotoxic T lymphocytes in vivo. J. Exp. Med. 179:865.
4. Auchincloss, H., Jr, Lee, R., Shea, S., Markowitz, J. S., Grusby, M. J. and Glimcher, L. H. 1993. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complexclass II-deficient mice. Proc. Natl Acad. Sci. USA 90:3373.
5. Wecker, H., Grusby, M. J. and Auchincloss, H., Jr 1995. Effector cells must recognize antigens expressed in the graft to cause efficient skin graft rejection in SCID mice. Transplantation 59:1223.
6. Dalloul, A. H., Chmouzis, E., Ngo, K. and Fung-Leung, W. P. 1996, Adoptively transferred CD4+ lymphocytes from CD8-/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts. J. Immunol. 156:4114.
7. Valujskikh, A., Matesic, D., Gilliam, A., Anthony, D., Haiqqi, T. M. and Heeger, P. S. 1998. T cells reactive to a single immunodominant self-restricted allopeptide induce skin graft rejection in mice. J. Clin. Invest. 101:1398.
8. Braun, M. Y., Grandjean, I., Feunou, P. et al. 2001. Acute rejection in the absence of cognate recognition of allograft by T cells. J. Immunol. 166:4879.
9. Hou, G., Valujskikh, A., Bayer, J., Stavitsky, A. B., Metz, C. and Heeger, P. S. 2001. In vivo blockade of macrophage migration inhibitory factor prevents skin graft destruction after indirect allorecognition. Transplantation 72:1890.
10. LaRosa, D. F., Rahman, A. H. and Turka, L. A. 2007. The innate immune system in allograft rejection and tolerance. J. Immunol. 178:7503.
11. Kitchens, W. H., Uehara, S., Chase, C. M., Colvin, R. B., Russell, P. S. and Madsen, J. C. 2006. The changing role of natural killer cells in solid organ rejection and tolerance. Transplantation 81:811.
12. Maier, S., Tertilt, C., Chambron, N. et al. 2001. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/-mice. Nat. Med. 7:557.
13. McNerney, M. E., Lee, K. M., Zhou, P. et al. 2006. Role of natural killer cell subsets in cardiac allograft rejection. Am. J. Transplant. 6:505.
14. Uehara, S., Chase, C. M., Kitchens, W. H. et al. 2005. NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts. J. Immunol. 175:3424.
15. Obara, H., Nagasaki, K., Hsieh, C. L. et al. 2005. IFN-gamma, produced by NK cells that infiltrate liver allografts early after transplantation, links the innate and adaptive immune responses. Am. J. Transplant. 5:2094.
16. Valujskikh, A., Lantz, O., Celli, S., Matzinger, P. and Heeger, P. S. 2002. Cross-primed CD8(+) T cells mediate graft rejection via a distinct effector pathway. Nat. Immunol. 3:844.
17. He, C. and Heeger, P. S. 2004. CD8 T cells can reject major histocompatibility complex class 1-deficient skin allografts. Am. J. Transplant. 4:698.
18. Kreisel, D., Krupnick, A. S., Gelman, A. E. et al. 2002. Non-hematopoietic allograft cells directly activate CD8+ T cells and trigger acute rejection: An alternative mechanism of allorecognition. Nat Med 8:233.
19. Kreisel, D., Krasinskas, A. M., Krupnick, A. S. et al. 2004. Vascular endothelium does not activate CD4+ direct allorecognition in graft rejection. J. Immunol. 173:3027.
20. Madsen, L., Labrecque, N,, Engberg, J. et al. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl Acad. Sci. USA 96:10338.
21. Ito, A., Minagawa, M., Tomiyama, K., Ito, M. and Kawai, K. 1999. Cytotoxic pathways in the skin allograft rejection by CD4+ T cells. Transplantation 68:97.
22. Shimura, H., Nitahara, A., Ito, A., Tomiyama, K., Ito, M. and Kawai, K. 2005. Up-regulation of cell surface Toll-like receptor 4-MD2 expression on dendritic epidermal T cells after the emigration from epidermis during cutaneous inflammation. J. Dermatol. Sci. 37:101.
23. Nitahara, A., Shimura, H., Ito, A., Tomiyama, K., Ito, M. and Kawai, K. 2006. NKG2D ligation without T cell receptor engagement triggers both cytotoxicity and cytokine production in dendritic epidermal T cells. J. Invest. Dermatol. 126:1052.
24. Girardi, M., Oppenheim, D. E., Steele, C. R. et al. 2001. Regulation of cutaneous malignancy by gammadelta T cells. Science 294:605.
25. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N. and Raulet, D. H. 2000. Ligands for the murine NKG2D receptor: Expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1:119.
26. Suttles, J., Schwarting, G. A. and Stout, R. D. 1986. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes. J. Immunol. 136:1586.
27. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225.
28. Raulet, D. H. 2003. Roles of the NKG2D immunoreceptor and its ligands. Nat. Rev. Immunol. 3:781.
29. Ogasawara, K., Benjamin, J., Takaki, R., Phillips, J. H. and Lanier, L. L. 2005. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat. Immunol. 6:938.
30. Kim, J., Chang, C. K., Hayden, T. et al. 2007. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection. J. Immunol. 179:6416.
31. Szot, G. L., Zhou, P., Rulifson, I. et al. 2001. Different mechanisms of cardiac allograft rejection in wildtype and CD28-deficient mice. Am. J. Transplant. 1:38.
32. Mistry, A. R. and O'Callaghan, C. A. 2007. Regulation of ligands for the activating receptor NKG2D. Immunology 121:439.
33. Hankey, K. G., Drachenberg, C. B., Papadimitriou, J. C. et al. 2002. MIC expression in renal and pancreatic allografts. Transplantation 73:304.
34. Ye, Z., Feng, L., Huang, S., Li, S., He, Y. and Li, Y. 2006. Expression of H60 on mice heart graft and influence of cyclosporine. Transplant. Proc. 38:2168.